APA (7th ed.) Citation

SE, G., JC, V., & RS, B. (2022). The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors. Current treatment options in oncology, 23(11), 1566. https://doi.org/10.1007/s11864-022-01024-5

Chicago Style (17th ed.) Citation

SE, Gueble, Vasquez JC, and Bindra RS. "The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors." Current Treatment Options in Oncology 23, no. 11 (2022): 1566. https://doi.org/10.1007/s11864-022-01024-5.

MLA (9th ed.) Citation

SE, Gueble, et al. "The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors." Current Treatment Options in Oncology, vol. 23, no. 11, 2022, p. 1566, https://doi.org/10.1007/s11864-022-01024-5.